SPARQL
Query
Update
Search
Quick
Advanced
Co-occurrence
RelFinder
About
Sources
Admin
System Info
Repository Management
Search Configuration
Sources
14662554
Source:
http://linkedlifedata.com/resource/pubmed/id/14662554
Search
Subject
(
67
)
Predicate
Object
All
Download in:
JSON
RDF
N3/Turtle
N-Triples
Switch to
Custom View
Named Graph
All
UniProt
NCBIGene
DrugBank
ClinicalTrials
UMLS
PubMed
Mappings
MentionedEntities
Language
All
English
Español
Português
Français
Deutsch
Русский
日本語
Български
Inference
Explicit and implicit
Explicit only
Implicit only
Statements in which the resource exists as a subject.
Predicate
Object
rdf:type
pubmed:Citation
lifeskim:mentions
umls-concept:C0018546
,
umls-concept:C0087111
,
umls-concept:C0171023
,
umls-concept:C0205178
,
umls-concept:C0338831
,
umls-concept:C1707455
pubmed:issue
12
pubmed:dateCreated
2003-12-9
pubmed:abstractText
This randomized controlled trial compares the efficacy and safety of olanzapine vs haloperidol, as well as the quality of life of patients taking these drugs, in patients with bipolar mania.
pubmed:language
eng
pubmed:journal
http://linkedlifedata.com/resource/pubmed/journal/0372435
pubmed:citationSubset
AIM
pubmed:chemical
http://linkedlifedata.com/resource/pubmed/chemical/Antipsychotic Agents
,
http://linkedlifedata.com/resource/pubmed/chemical/Benzodiazepines
,
http://linkedlifedata.com/resource/pubmed/chemical/Haloperidol
,
http://linkedlifedata.com/resource/pubmed/chemical/Pirenzepine
,
http://linkedlifedata.com/resource/pubmed/chemical/olanzapine
pubmed:status
MEDLINE
pubmed:month
Dec
pubmed:issn
0003-990X
pubmed:author
pubmed-author:AzorinJean MJM
,
pubmed-author:BakerRobert WRW
,
pubmed-author:BreierAlanA
,
pubmed-author:EmsleyRobin ARA
,
pubmed-author:EvansAngela RAR
,
pubmed-author:GoldbergJoseph FJF
,
pubmed-author:Gonzalez-Pinto ArrillagaAna MariaAM
,
pubmed-author:Hardy-BayleMarie-ChristineMC
,
pubmed-author:LawsonWilliam BWB
,
pubmed-author:NamjoshiMadhav AMA
,
pubmed-author:RisserRichard CRC
,
pubmed-author:TohenMauricioM
,
pubmed-author:VietaEduardE
,
pubmed-author:ZhangFanF
pubmed:issnType
Print
pubmed:volume
60
pubmed:owner
NLM
pubmed:authorsComplete
Y
pubmed:pagination
1218-26
pubmed:dateRevised
2008-11-21
pubmed:meshHeading
pubmed-meshheading:14662554-Acute Disease
,
pubmed-meshheading:14662554-Adult
,
pubmed-meshheading:14662554-Antipsychotic Agents
,
pubmed-meshheading:14662554-Benzodiazepines
,
pubmed-meshheading:14662554-Bipolar Disorder
,
pubmed-meshheading:14662554-Dose-Response Relationship, Drug
,
pubmed-meshheading:14662554-Double-Blind Method
,
pubmed-meshheading:14662554-Drug Administration Schedule
,
pubmed-meshheading:14662554-Female
,
pubmed-meshheading:14662554-Haloperidol
,
pubmed-meshheading:14662554-Humans
,
pubmed-meshheading:14662554-Male
,
pubmed-meshheading:14662554-Middle Aged
,
pubmed-meshheading:14662554-Personality Inventory
,
pubmed-meshheading:14662554-Pirenzepine
,
pubmed-meshheading:14662554-Psychiatric Status Rating Scales
,
pubmed-meshheading:14662554-Treatment Outcome
pubmed:year
2003
pubmed:articleTitle
A 12-week, double-blind comparison of olanzapine vs haloperidol in the treatment of acute mania.
pubmed:affiliation
Lilly Research Laboratories, Indianapolis, Ind 46225, USA. m.tohen@lilly.com
pubmed:publicationType
Journal Article
,
Clinical Trial
,
Comparative Study
,
Randomized Controlled Trial
,
Research Support, Non-U.S. Gov't
,
Multicenter Study